Best Evidence Analyses and Commentary

Browse...

Search...

Millcreek Health Systems Affiliates

News Briefs - Archives

SELECT Client_ID, Account_ID, Content_ID, Headline, SubHead, URLLink, AvailableDate, DateLine, ContentCategory_ID, SortOrder FROM mgContent WHERE ContentCategory_ID = 28853 AND Client_ID = 240 AND isComment <> 1 AND (isModerated = 0 OR (isModerated = 1 AND ApprovedByUser <> 0)) ORDER BY AvailableDate DESC

Xanodyne agrees to withdraw propoxyphene from the U.S. market - November 19, 2010
FDA approves Xgeva to help prevent cancer-related bone injury - November 19, 2010
FDA approves Egrifta (tesamorelin) to treat Lipodystrophy in HIV patients - November 08, 2010
FDA Approves Teflaro for Bacterial Infections - November 05, 2010
FDA clears Cymbalta to treat chronic musculoskeletal pain - November 05, 2010
FDA approves Latuda to treat schizophrenia in adults - November 05, 2010
FDA Drug Safety Communication: FDA Recommends Against the Continued Use of Meridia (sibutramine) - November 05, 2010
FDA approves additional medical indication for Sprycel - November 05, 2010
FDA reminder to avoid concomitant use of Plavix (clopidogrel) and omeprazole - November 05, 2010
FDA Drug Safety Podcast for Healthcare Professionals: Safety update for osteoporosis drugs, bisphosphonates, and atypical fractures - November 05, 2010

Website Terms of Use Disclaimer | E-mail Terms of Use | Contact LECOM |